View clinical trials related to Vaccine Response.
Filter by:The STOPCoV study is a decentralized study comparing COVID-19 vaccine specific antibody levels at 24 weeks after final vaccine dose. We plan to study the safety and immunogenicity of COVID-19 vaccine(s) in community dwelling persons 70 years and over relative to a younger group (aged 30 - 50 years).
This study will evaluate the impact of sleep, circadian health and melatonin on flu vaccine immunogenicity.